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1. INTRODUCTION 
The caudate nucleus region of mammalian brain 
which is innervated by dopaminergic neurons 
contains dopamine-stimulated adenylate cyclase 
[l-5]. This observation together with other evi- 
dence [6-S] led to the suggestion that the effects of 
dopamine in the central nervous system are 
mediated through the activation of adenylate 
cyclase. However, it has been established that there 
are two classes of dopamine receptor Dr and D2 
and that only Dr receptors are coupled to adenylate 
cyclase [9-l 11. Dr receptors may also be restricted 
to a minor component of the caudate nucleus 
[12,13]. It may not be surprising, therefore, that in 
isolated plasma membranes from bovine caudate 
nucleus we find that adenylate cyclase is not acti- 
vated by dopamine. However, the process of mem- 
brane purification may impair the function of 
adenylate cyclase. The aim of this study was to test 
whether bovine caudate nucleus adenylate cyclase 
can respond to any hormone receptor. To this end 
we fused rat liver plasma membranes containing a 
functional glucagon receptor with brain mem- 
branes, using the polyethylene glycol method in 
[ 14,151. After fusion, glucagon stimulated caudate 
nucleus adenylate cyclase showing that the enzyme 
is able to functionally couple to a foreign hormone 
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receptor. We conclude that it is unlikely that these 
membranes contain dopamine receptors which 
stimulate adenylate cyclase. 
2. EXPERIMENTAL 
2.1. Preparation of membranes 
Rat liver plasma membranes were prepared as in 
[16] and bovine caudate nucleus plasma mem- 
branes as in [ 171. Protein concentrations were 
determined by a scaled down modification of the 
method in [18]. 
2.2. Determination of adenylate cyclase activity 
Adenylate cyclase activity was assayed at 30°C 
in a mixture containing 50 mM Tris-HCI (pH 7.4) 
10 mM MgClz, 1 mM cyclic 3’,5’-AMP, 1 mM di- 
thiothreitol, 5 units of creating kinase, 20 mM 
creatine phosphate, 1% bovine serum albumen, 
0.5 mM ATP and [a-32P]ATP to spec. act. 12 
cpm/pmol. The incubation was stopped and cyclic 
3’,5’-AMP separated from other nucleotides as in 
1191. 
2.3. Fusion of rat liver plasma membranes with 
nucleus plasma membranes 
The fusion procedure follows that in [ 14,151. 
Rat liver plasma membranes were suspended in 
20 mM Tris-HCI (pH 7.4) at 2 mg membrane pro- 
tein/ml at 0°C. Freshly prepared ice-cold solution 
of N-ethylmaleimide (44 ~1 50 mM) was added 
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dropwise with continuous mixing to 400 ~1 mem- 
brane suspension to give 5 mM final cont. The 
mixture was incubated for 5 min at 0°C and the 
reaction was then stopped by the addition of 10 ~1 
250 mM dithiothreitol. The mixture was spun for 
2 min at 4°C in a microfuge. The pellet was gently 
blotted with a tissue and resuspended in 1.5 ml ice- 
cold buffer containing 20 mM Tris-HCl (pH 7.4), 
2 mM MgClz and 1 mM EDTA (TME buffer). 
Sonicated suspension (40 ml) of crude asolectin 
(1 mg/ml) and 15 ~1 1 M MgClz were added one at 
a time and mixed and the mixture was incubated at 
0°C for 10 min. A sample (500 ~1) was removed to 
determine the adenylate cyclase activity of the liver 
membranes prior to fusion and the remaining 
suspension centrifuged for 2 min at 0°C in a 
microfuge. The pellet was blotted as before and 
100 ~1 of a 2 mg/ml suspension in TME buffer of 
bovine caudate nucleus plasma membranes was 
layered over the liver membrane pellet. The tube 
was centrifuged as before and the supernatant 
discarded. The combined pellet was incubated at 
30°C for 5 min and 0.5 ml of a freshly prepared 
solution of polyethylene glycol 6000 (PEG) (52%, 
w/w) were added. The pellet was resuspended this 
requiring vigorous mixing and taking -40 s and 
the tube returned to a 30°C water bath. At 2 min 
after the addition of the polyethylene glycol solu- 
tion and at 2 min intervals thereafter the following 
volumes of TME buffer at 30°C were added with 
mixing: 0.2, 0.3, 0.5, 1.5, 3.0, 5.0, 7.0 ml. The 
mixture was then centrifuged at 20000 x g for 
10 min at 0°C in an angle rotor. The supernatant 
was carefully decanted and the pellet was 
resuspended in 400~1 of ice-cold TME buffer 
giving -650 ~1 suspension total volume. 
3. RESULTS AND DISCUSSION 
The response of rat liver plasma membrane 
adenylate cyclase to glucagon and guanine nucleo- 
tides is shown in fig. IA. GTP stimulated basal 
activity by 1.7-fold and p(NH)ppG by &fold over 
20 min at 30°C. Glucagon increased the basal acti- 
vity by 1.7-fold, the activity in the presence of GTP 
by 3-fold and the activity in the presence of 
p(NH)ppG by 1.7-fold. Preincubation of liver 
plasma membranes with 5 mM N-ethylmaleimide 
for 10 min at 0°C almost abolished adenylate 
cyclase activity under any experimental condition 
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(fig. 1A). Treatment of liver plasma membranes 
with polyethylene glycol (PEG) following the same 
protocol used in the fusion process caused a 
3-4-fold reduction in activity under all experimen- 
tal conditions, probably reflecting inactivation of 
the catalytic unit. In contrast the PEG treatment 
had little effect on the adenylate cyclase activity of 
brain plasma membranes (fig. 1B). GTP stimu- 
lated the basal activity of untreated membranes or 
of PEG treated membranes by -1.7-fold and 
p(NH)ppG by -3-4-fold, respectively. Glucagon 
had no effect on the adenylate cyclase activity of 
either native brain membranes or brain membranes 
which had been treated with PEG. We also tested 
the effect of addition of the crude phospholipid 
preparation asolectin since in [14] the presence of 
asolectin improved the fusion of liver plasma mem- 
branes with Friend erythroleukemia cell plasma 
membranes. Here, we found that asolectin over 
60-240 pg/48 pg plasma membrane protein had 
no effect on the activity of adenylate cyclase in 
either the liver or brain plasma membranes and no 
effect on the fusion procedure. 
The procedure for the fusion of liver plasma 
membranes with brain plasma membranes is de- 
tailed in section 2. After fusion of N-ethylmalei- 
mide treated liver plasma membranes with brain 
plasma membranes, the brain adenylate cyclase in 
the fused membranes was activated by glucagon 
(fig. lC, fig. 2). The stimulation of basal activity 
was 1.9-fold which is comparable with the stimula- 
tion in native liver membranes. In the presence of 
GTP the stimulation by glucagon was 1.3-fold and 
in the presence of p(NH)ppG 1.2-fold. This is con- 
siderably less than the stimulation in native liver 
membranes. In the absence of glucagon the activity 
was comparable with the activity in brain plasma 
membranes which had been treated with PEG. The 
experiment shown in fig. 1C is representative of 8 
successful fusion expt. In only 1 expt was there no 
response to glucagon. The data from 7 expt are 
summarised in table 1. In the last column, the ratio 
of the (p(NH)ppG + glucagon)-stimulated activity 
to the glucagon-stimulated activity is given. This 
ratio may be taken as a qualitative assessment of 
the effectiveness of the coupling after fusion. It is 
clear that the activation is less effective in the fused 
membranes than in native liver membranes. How- 
ever, the basal specific activity of brain membranes 
was much higher than the basal specific activity of 
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Fig. 1. Rat liver and bovine caudate nucleus plasma membranes were fused as in section 2. Adenylate cyclase assay incu- 
bations were for 20 min at 30°C. The following preparations were assayed: (A) liver plasma membranes (10 pg/assay) 
before and after treatment with PEG and N-ethylmaleimide; (B) brain plasma membranes (6 pg/assay) before and after 
treatment with PEG; (C) liver membranes pretreated with N-ethylmaleimide (16pg/assay) fused with brain plasma 
membranes (6 pg/assay); (D) brain plasma membranes pretreated with NEM (22 pug/assay) fused with liver plasma mem- 
branes (6pg/assay). This experiment followed the above protocol except that brain adenylate cyclase activity was 
destroyed by N-ethylmaleimide and replaced the liver as donor; (E) a mixture of liver plasma membranes (5 pg/assay) 
and brain plasma membranes (1.5 pg/assay) not treated with PEG but incubated at 30°C for the same time as the PEG 
treatment (14 min). 
Basal GTP owmDC 
Fig. 2. Time course of cyclic AMP production generated 
by brain adenylate cyclase fused with liver membranes 
which were treated with N-ethylmaieimide. Fusion was 
performed as in section 2. The concentration of NEM- 
treated liver membrane was varied from 16.4pg 
(A,B,C)-32.8 pg (D,E,F)/6 pg of brain membranes. 
Adenylate cyclase activity was determined as in section 
2. Control incubations are shown by open symbols, incu- 
bations in the presence of lo-’ M glucagon by closed 
symbols. The control incubations for the fusion were as- 
sayed in duplicate at 30 min: (m) NEM-treated liver 
membranes; (0) PEG-treated brain membranes in the 
0 10 20 30 40 0 10 20 30 40 0 10 20 30 40 presence or the absence of glucagon. There was no effect 
Tlrn@ ml” of glucagon. 
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Table 1 
Activation ratios elicited by glucagon, GTP and GppNHp in the various membrane preparations 
Membrane Basal GTP P(NH)PPG GTP p(NH)ppG + glucagon 
preparation + glucagon/ + glucagon/ + glucagon/ 
- glucagon - glucagon glucagon - basal basal + glucagon 
Liver 2.5 * 0.2 3.0 Ik 1.0 1.7 * 0.4 1.7 + 0.1 3.8 ZII 0.32 
n=3 
Liver PEG 3.5 * 0.1 2.5 f 0.27 2.0 f 0.2 2.5 + 0.28 4.0 * 0.4 
n=l 
Brain 1.0 * 0.1 1.0 f 0.1 1.0 t 0.1 1.6 + 0.2 3.0 * 0.3 
n=3 
Brain PEG 1.0 + 0.1 1.0 -t 0.1 1.0 f 0.1 1.7 * 0.4 4.2 k 0.2 
n=3 
Liver + Brain 1.8 + 0.08 1.8 k 0.02 1.9 + 0.02 2.0 + 0.08 4.0 + 0.2 
n=l 
Liver NEM + brain fused 1.57 + 0.24 1.32 f 0.2 1.175 + 0.17 1.7 + 0.3 2.2 + 0.15 
n=7 (n = 5) 
The fusion, treatment of membranes with NEM and PEG and the adenylate cyclase determinations was as in section 
2. Glucagon was added at lo-’ M, GTP and p(NH)ppG at 10e4 M. The standard deviations are presented in each case, 
where n >l; otherwise the average and limits are given. Each experimental condition was assayed in duplicate. n = no. 
individual expt. 
liver membranes and the stimulation by p(NH)ppG 
was only 3-4-fold in the brain compared to &fold 
in the liver. The p(NH)ppG-stimulated state in 
these systems is probably close to the maximum 
possible adenylate cyclase activity. Thus the poten- 
tial range of glucagon activation working on brain 
adenylate cyclase is less and it is not therefore sur- 
prising that the actual activation is also less. 
When brain plasma membranes were treated 
with N-ethylmaleimide to inhibit adenylate cyclase 
and then fused to untreated liver plasma mem- 
branes, the liver plasma membrane adenylate 
cyclase was still activated by glucagon (fig. 1D). 
However, the activation was slightly less than in 
native membranes. The adenylate cyclase activity 
of a mixture of liver plasma membranes and brain 
plasma membranes which had not been treated 
with NEM or fused corresponded for the most part 
to the sum of the activities of the individual mem- 
brane preparations. It appears therefore that fusion 
is required for glucagon to activate brain adenylate 
cyclase and no loosely bound factor is able to 
transmit the message from the hormone receptor in 
one plasma membrane to adenylate cyclase in the 
other. 
The time course of adenylate cyclase activity in 
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brain plasma membrane fused with N-ethylmalei- 
mide-treated liver plasma membrane is shown in 
fig. 2. The stimulation by glucagon in the fused 
membranes was dependent upon the ratio of liver 
plasma membranes to brain plasma membranes 
used in the fusion. Increasing the liver plasma 
membrane protein from a protein ratio of 2.5: 1 
compared to the brain membrane to 5 : 1 increased 
the response to glucagon. Further increases in the 
ratio of liver membrane protein to brain membrane 
protein did not increase the response to glucagon. 
Dopamine did not activate adenylate cyclase in the 
brain membranes either before or after fusion to 
liver plasma membranes which had been treated 
with NEM. 
The stimulation of brain adenylate cyclase by 
glucagon is a convincing demonstration of func- 
tional coupling of the glucagon receptor to adeny- 
late cyclase. This implies that the liver plasma 
membrane and brain plasma membranes have 
fused. It was also possible to separate the fused 
membranes from unfused liver and brain plasma 
membranes on a sucrose gradient. The buoyant 
density of liver plasma membranes is greater than 
that of brain plasma membranes. It seemed likely 
therefore that the fused membranes would have a 
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Fig. 3. Separation of liver, brain and fused plasma 
membranes on a sucrose gradient. Liver and brain mem- 
branes were fused as in section 2. Sucrose, 2.5 ml 50% 
(w/v) and 2.5 ml 20% (w/v), was used to form a 
20-50% linear gradient of 5 ml total vol. Between 
300-400 ~1 of membrane suspension (0.8 mg total mem- 
brane protein) were applied to the top of the gradient 
which was then centrifuged at 100000 x g for 90 min in 
a swingout rotor (Beckman). The tubes were photo- 
graphed against a background with lighting from below 
and behind at a slight angle. 
buoyant density intermediate between the two and 
that this could be used as a method of separation. 
The results of centrifugation on a 20-50% (w/v) 
sucrose gradient are shown in fig. 3. Liver 
membranes were clearly separated from brain mem- 
branes and this was not affected when the 
membranes were mixed. Treatment with polyethy- 
lene glycol slightly reduced the density of the brain 
membranes and caused a more marked reduction 
in the density of the liver membranes. This reduc- 
tion in density probably reflects the fact that 
polyethylene glycol remained associated with the 
membranes even after washing. However, there 
was still a clear separation. The fused membranes 
formed a somewhat more diffuse band between the 
polyethylene glycol-treated liver and brain mem- 
branes. This confirms the conclusion that the 
membranes have fused, and also provides a means 
of separation of fused membranes from residual 
unfused material which will be of great value in 
further studies. 
These experiments show that brain adenylate 
cyclase will couple to a hormone receptor leading 
to activation. The lack of response to the dop- 
amine receptor in the native membranes cannot 
therefore be explained by a defect in the catalytic 
unit of the brain enzyme. This leaves the possibility 
of a lack of function in either the GTP binding 
protein (G/F) which is thought to mediate the 
coupling between receptors and adenylate cyclase 
[20] or in the dopamine receptor. In one strain of 
S49 lymphoma cells there is a defect in the G/F 
subunit which allows the activation of adenylate 
cyclase by GTP and p(NH)ppG while not allowing 
activation by hormone receptors [21]. This could 
be analogous to the situation in the native brain 
membranes. Nevertheless, a lack of function of 
native brain G/F cannot account for the lack of 
dopamine response in the fused membranes. A 
G/F protein which mediates the activation of 
adenylate cyclase by one hormone receptor seems 
to be always able to mediate activation by any 
other receptor present [22-241. Thus, the activa- 
tion of brain adenylate cyclase in the fused mem- 
branes by glucagon points to the presence of a 
functional G/F protein. The lack of response to 
dopamine in the fused membranes therefore im- 
plies that the dopamine receptors cannot func- 
tionally couple with the other components of the 
system. Whether the G/F subunit in the fused 
membranes is derived from the liver plasma mem- 
branes or the brain plasma membranes is not clear 
at present. 
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